Pfizer (PFE) Tops Q2 EPS by 11c, Updates FY Guidance

Pfizer (NYSE: PFE) reported Q2 EPS of $1.07, $0.11 better than the analyst estimate of $0.96. Revenue for the quarter came in at $19 billion versus the consensus estimate of $18.45 billion.

GUIDANCE:

Pfizer sees FY2021 EPS of $3.95-$4.05, versus the consensus of $3.70. Pfizer sees FY2021 revenue of $78-80 billion, versus the consensus of $72.78 billion.

For earnings history and earnings-related data on Pfizer (PFE) click here.

You May Also Be Interested In

• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance
• Amer Sports, Inc. (AS) Tops Q2 EPS by 11c; raises guidance
• Keysight Technologies (KEYS) Tops Q3 EPS by 59c; Offers Guidance